Dr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity | Huberman Lab
Guest appearances — Dr. Craig Koniver, MD — Dr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity | Huberman Lab
Channel: Podcast Summaries · Our label: Guest appearance — Dr. Craig Koniver, MD as guest on host channels. The host channel is named on every page. · Source: youtube.com/watch?v=QZr97DPMnr0
Guest appearance: Dr. Craig Koniver, MD appears as a guest on Podcast Summaries. This page is filed under the host channel and tagged as a guest appearance in our library.
What this video covers
Craig Koniver, a medical doctor specializing in performance medicine, explores the rise of peptide therapies and their potential to enhance mental and physical health. He discusses various peptides, including GLP-1 agonists for weight management, BPC-157 for healing, growth hormone secretagogues for vitality, and the importance of mindset in overall well-being. Koniver also addresses regulatory challenges and the significance of informed health choice in navigating this evolving landscape. Koniver begins by discussing the peptide therapies, which are…
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Craig Koniver, a medical doctor specializing in performance medicine, explores the rise of peptide therapies and their potential to enhance mental and physical health.
- He discusses various peptides, including GLP-1 agonists for weight management, BPC-157 for healing, growth hormone secretagogues for vitality, and the importance of mindset in overall well-being.
- Another peptide discussed is BPC-157, known for its anti-inflammatory properties and potential to aid in injury recovery.
- Koniver shares his clinical experiences, noting its effectiveness in reducing inflammation and promoting healing in various conditions, including post-viral symptoms and musculoskeletal injuries.
- Koniver addresses the recent FDA restrictions on BPC-157 and other peptides, which have been categorized as no longer allowable for compounding pharmacies.
- The conversation touches on GLP-1 agonists, which are FDA-approved for weight management and metabolic health.
Read next
- BPC-157 — compound page
- GLP-1 class — more videos
- Semaglutide — more videos
- Ipamorelin — more videos
- Sermorelin — more videos
- GHRP-6 — more videos
- All videos from this channel
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.